|
MDRNA, Inc. Completes Exclusive License Agreement to RNAi Delivery Peptides
20 August 2008
The Company licenses intellectual property from the University of Michigan covering cationic peptides for enhanced delivery of nucleic acids.
|
|
|
|
Bio-Rad Announces Mini-Protean Tetra Cell Users Website
20 August 2008
The new online social networking site is created for current and new Bio-Rad Mini-PROTEAN® system users.
|
|
|
|
Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
20 August 2008
Under this discovery and development collaboration, Omeros will continue to advance the development of its MASP-2 program.
|
|
|
|
Medco Announces Research Collaboration with FDA Focused on Personalized Medicine
19 August 2008
Study to report findings on how genes impact efficacy of many commonly used prescription medications.
|
|
|
|
Eden Biodesign Signs Marketing Services Agreement with Human Genome Sciences
19 August 2008
Both companies will use their combined expertise to provide customers with transition into cGMP manufacturing at scales up to 20,000L.
|
|
|
|
454 Sequencing System Used to Determine the Complete Neanderthal Mitochondrial Genome
19 August 2008
Researchers have published the complete Neanderthal mitochondrial genome sequence that was generated using the 454 Sequencing technology.
|
|
|
|
454 Sequencing System Used to Determine the Complete Neanderthal Mitochondrial Genome
19 August 2008
Researchers have published the complete Neanderthal mitochondrial genome sequence that was generated using the 454 Sequencing technology.
|
|
|
|
Interleukin Genetics Licenses its PST® Genetic Test to OralDNA Labs
18 August 2008
OralDNA receives a non-exclusive license to market, sell and distribute Interleukin Genetics' PST® Genetic Test to dental practices within the U.S.
|
|
|
|
University of Nevada Deploys Proteus by GenoLogics for their Data Management System
14 August 2008
The University has selected GenoLogics to install their informatics solution to aggregate data from several proteomic technological platforms.
|
|
|
|
Tekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb
14 August 2008
Bristol-Myers Squibb to use Tekmira's SNALP technology to deliver siRNAs to specific organs and tissues outside of the liver.
|
|
|
|
Sloan-Kettering Institute to Use GeneBio’s Phenyx Protein ID Platform
14 August 2008
Sloan-Kettering Institute has licensed GeneBio’s PhenyxServer protein identification and characterization software to be used in the laboratory of Paul Tempst.
|
|
|
|
Sense Proteomic Ltd Expands its IP Portfolio by Filing Lupus Biomarker Patent
14 August 2008
Sense Proteomic files patent on a panel of autoantibody biomarkers for the early diagnosis and monitoring of Systemic Lupus Erythematosus.
|
|
|
|
Promega and Leica Microsystems Sign Agreement to Develop Fluorescent Ligands
14 August 2008
Promega will develop fluorescent ligands for its HaloTag fusion proteins, to label proteins within live cells so that they can be visualized with Leica’s TCS STED.
|
|
|
|
Ocimum Biosolutions Announces Genomic Pioneer Awards
14 August 2008
The purpose of the Genomic Pioneers Award is to recognize excellence and outstanding contribution to the field of genomics using integrated approaches.
|
|
|
|
Molecular Switch Boosts Brain Activity Associated with Schizophrenia
14 August 2008
Researchers have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of brain electrical activity.
|
|
|
|
Likely Cause of Postpartum Blues and Depression Identified
14 August 2008
Unique biochemical crosstalk that enables a fetus to get nutrition and oxygen from its mother's blood just may cause common postpartum blues.
|
|
|
|
Lab21 to Market deCODE Tests for Assessing Risk of Common Diseases
13 August 2008
The licence allows Lab21 to offer its clients in the UK and Ireland access to new tests to confer risk of common diseases.
|
|
|
|
Isogen Biosolutions B.V. is now Ocimum Biosolutions B. V.
13 August 2008
Isogen has rebranded itself as Ocimum Biosolutions B. V. to tap the emerging opportunities and need for globalized solutions in Genomics.
|
|
|
|
Gentel® Obtains License from Agnitio for Protein Microarray Technology
13 August 2008
The technology, developed by Agnitio and Technology of Hsinchu, Taiwan, covers the use of ultrasonic coating to produce nitrocellulose films.
|
|
|
|
Genetic Biomarker Linked to Subcutaneous Growth Hormone Dose-Response
13 August 2008
German scientists show that a genetic biomarker may explain individual differences in the required dosage of subcutaneously injected recombinant hGH.
|
|
|
|
Biocore and AnaSpec Sign Distributor Agreement
13 August 2008
The agreement will allow Biocore to distribute AnaSpec’s catalog and custom products throughout Australia.
|
|
|
|
BioNanomatrix Awarded NIH Grant for Development of Nanoscale Platform
13 August 2008
Goal is development of a fully integrated nanochannel chip and reader for single-molecule mapping.
|
|
|
|
AGOWA Genomics Adds the Roche Genome Sequencer FLX System to Its Sequencing Portfolio
13 August 2008
The acquisition of the Roche GS FLX will enable AGOWA genomics to meet the market demands for higher capacity and higher throughput.
|
|
|
|
Agilent Technologies Appoints IMGM Laboratories Certified Service Provider for Gene Expression Microarrays
13 August 2008
IMGM achieved Agilent-certified status after completing training and passing a rigorous series of assessments.
|
|
|
|
Designer RNA Fights High Cholesterol, Researchers Find
12 August 2008
Small RNA can interfere with cholesterol metabolism, reducing harmful cholesterol by two-thirds in pre-clinical tests.
|
|
|
|
Agilent Technologies Microarrays Selected by Wellcome Trust Case Control Consortium
12 August 2008
Landmark human genome copy number variation study of 19,000 DNA samples aimed at genetic causes of 11 widespread diseases.
|
|
|
|
Harvard University and Oxford Nanopore Technologies Announce Licence Agreement
11 August 2008
The agreement aims to progress nanopore science by integrating Harvard discoveries with technology in development at Oxford Nanopore.
|
|
|
|
Researchers Uncover West Nile’s Targets
08 August 2008
Screening the entire human genome, a team headed by Yale University scientists has identified several hundred genes that impact West Nile virus infection.
|
|
|
|
Researchers Discover Remnant of an Ancient ‘RNA World’
08 August 2008
Yale researchers describe some bacterial cells can swim, morph into new forms and even become dangerously virulent.
|
|
|
|
Recipe for Cell Reprogramming Adds Protein
08 August 2008
A drug-like molecule can be substituted for the cancer gene c-Myc, one of four genes added to adult cells to reprogram them to an embryonic-stem-cell-like state, says Whitehead researchers.
|
|
|
|
iZumi Bio Recruits iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough Into Patient Benefits
07 August 2008
California venture will use personalized stem cell technology to battle disease.
|
|
|
|
Invitrogen, Lentigen to Provide Lentivirus Products and Services for Gene Over-Expression
05 August 2008
Invitrogen will provide access to its extensive human and mouse gene libraries for use by Lentigen for the development of ready-to-use lentiviral particles.
|
|
|
|
Alnylam Consolidates Intellectual Property for RNA Activation
05 August 2008
Company completes exclusive license agreements with UT Southwestern Medical Center, UCSF, and the Salk Institute for Biological Studies.
|
|
|
|
Roche NimbleGen CGH Arrays Enable Detection of the Genomic Disorder Resulting in Diabetes
05 August 2008
Using CGH technique, researchers identified a recurrent reciprocal genomic rearrangement of chromosomal region 17q12 in fetal samples with congenital anomalies.
|
|
|
|
Studies to Assess Risk of Exposure to Elevated Levels of EMS Confirm Clear Toxicity Threshold for DNA Damage
05 August 2008
Studies emphasize lack of cancer risk for patients exposed to this impurity in Viracept.
|
|
|
|
Silence Therapeutics Receives Allowance from USPTO for its Core RNAi Patent
05 August 2008
U.S. AtuRNAi patent allowance builds on European equivalent granted in 2007, expanding commercial protection.
|
|
|
|
Roche Diagnostics Licenses Melting Curve Analysis Technique to Agilent Technologies
04 August 2008
Under the terms of the agreement, Agilent obtains a non-exclusive license to use, develop and sell products based on melting curve analysis.
|
|
|
|
Increased Burden of Rare Genetic Variations Found in Schizophrenia
04 August 2008
Two new sites of deletions implicated in the study that triples the number of genomic areas definitely linked to schizophrenia.
|
|
|
|
NuGEN Receives Patent for Global Nucleic Acid Amplification
04 August 2008
The patent describes a global whole genome amplification methodology using composite DNA/RNA primers able to anneal to multiple sites within the template polynucleotide.
|
|
|
|
deCODE and SGENE Consortium Discover Deletions in the Human Genome Linked to Risk of Schizophrenia
04 August 2008
Findings may provide the foundation for a test to complement standard clinical diagnosis, potentially enabling earlier intervention and treatment.
|
|
|
|
Liver Damage in Hepatitis C Patients Could be Treated with Warfarin
01 August 2008
The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.
|
|
|
|
Mechanism for Postpartum Depression Found in Mice
01 August 2008
Researchers have pinpointed a mechanism in the brains of mice that could explain why some human mothers become depressed following childbirth.
|
|
|
|
Alzheimer's Disease Patients Show Improvement in Trial of new Drug
30 July 2008
A new drug has been shown to improve the brain function of Alzheimer's patients and reduce a key protein associated with the disease in the spinal fluid.
|
|
|
|
Roche Diagnostics Licenses Melting Curve Analysis Technique to Agilent
30 July 2008
Under the terms of the agreement, Agilent will obtain from Roche a non-exclusive license to use, develop and sell products based on melting curve analysis.
|
|
|
|
Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers
30 July 2008
Nuvelo has enrolled the first subject in a single-center, Phase 1 trial of the company's lead compound from its Wnt Therapeutics Program.
|
|
|
|
WaferGen Signs Exclusive Distribution Agreements for SmartSlide Micro-Incubation System
29 July 2008
The agreement covers distribution of SmartSlide products through Bucher Biotec in Switzerland, Unimed Healthcare in Taiwan and AH diagnostics in Nordic region.
|
|
|
|
Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
29 July 2008
The licensing agreement allows Novus to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes.
|
|
|
|
GeneSeek Becomes Illumina's First Certified Service Provider to Use Infinium DNA Analysis BeadChips for Agriculture Research
29 July 2008
GeneSeek offers its customers access to large-scale interrogation of plant and animal genomes using Illumina's Infinium® products.
|
|
|
|
One Missing Gene Leads to Fruitless Mating Rituals
28 July 2008
Male fruit flies missing a gene for one particular odor receptor become clueless in matters of love, Duke researchers discovered.
|
|
|
|
Researchers Discover a Gene that Regulates and Blocks Ovulation
28 July 2008
A group of Canadian and European researchers have unlocked the mystery of a gene with the potential to both regulate and block ovulation.
|
|
|